BioFinance 2012 Draft Program

Click the icon to download the program

Seminars on May 29th must still be confirmed. Once determined, BioFinance participants must individually RSVP directly to any seminar they wish to attend on May 29th. Contact information will be provided.


Tuesday May 29, 2012, 27th Floor
1:00 – 5:00 pm The MaRS Innovation Early Stage Technology Showcase
1:00 – 2:00 pm TSX & TSX Venture - Accessing Public Capital for Life Science Companies
2:00 – 4:00 pm A TMX Equicom Investor Relations Seminar for Public and Private Companies
4:00 – 6:00 pm Economic Briefing and M&A Insights Sponsored by RBC Royal Bank and PwC
6:00 – 8:00 pm  BioFinance Opening Reception - 16th Floor
Wednesday May 30, 2012, 27th Floor
8:00 – 9:00 am
Room A
Breakfast with Dealmakers – U.S. Venture Capital Panel
9:00 – 12:00 pm
Rooms 1 & 2
Life Science Company Presentations
9:00 – 10:00 am
Room A
Mergers & Acquisitions in the Life Sciences
9:00 – 10:00 am
Room B
Strategic Alliances – The Pharma Perspective
10:00- 11:00 am
Room A
IPO Readiness – When The Window Opens
10:00 –11:00 am
Room B
Strategic Alliances – The Biotech Perspective
11:00 – 12:00 pm
Room A
Exits & Other Opportunities
11:00 – 12:00 pm
Room B
Canadian Venture Capital
12:00 – 2:00 pm
Room A
Luncheon with Dealmakers
12:45 – 1:00 pm
Room B
Canadian Public Markets for the Life Sciences
2:00 – 5:00 pm
Rooms 1 & 2
Life Science Company Presentations
1:00 - 2:00 pm
Room B
View from Wall Street - U.S. Investment Bankers
2:00 – 3:00 pm
Room A
Alternatives to an Initial Public Offering
3:00 – 4:00 pm
Room A
Genomics Enterprise in Canada
4:00 - 5:00 pm
Room B
Government Funding for Early Stage Companies
4:00 – 5:00 pm
Room A
Government Funding Programs for Early Stage Companies
5:00 – 8:00 pm Sponsors' Receptions